Global Regulatory Submissions for QbD: Wyeth's Experience in the CMC Pilot

Representatives of one pilot program participant, Wyeth, outline the experiences and lessons learned for implementing a science- and risk-based approach to drug-development and manufacturing.
Oct 02, 2009
Volume 33, Issue 10